Miami GU Oncology Summit

Venue: Hyatt Regency Miami, 400 Southeast 2nd Street, Miami, FL, 33131, United States

Start Date: November 14, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

21+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binaytara

Bruno R Bastos, MD

Conference Co-Chair

Mount Sinai Medical Center

Rohan Garje, MD

Conference Co-Chair

Miami Cancer Institute

Leonardo D. Borregales, MD

Planning Committee

Mount Sinai Medical Center

Arnab Basu, MD

Planning Committee

Mayo clinic

Brandon Mahal, MD

Planning Committee

University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL, USA

Faculty

Rohan Garje, MD

Session Chair

Miami Cancer Institute

Michael Carducci, MD

Session Chair

John Hopkins University

Manuel Ozambela, MD

Session Chair

Baptist Health

Daniel Vilarim Araujo, MD

Session Chair

University of Florida

Leslie V Castaneda, MPH

Topic Presenter

Miami Cancer Insititute at Baptist Health South Florida

Isabel Houlzet, PharmD

Topic Presenter

Mount Sinai Medical Center

Jingsong Zhang, MD, PhD

Topic Presenter

Moffitt Cancer Center

Mike Liu, MD

Topic Presenter

Moffitt Cancer Center

Rohit Jain, MD

Topic Presenter

Weill Cornell Medicine/New York-Presbyterian Hospital

Ulka Vaishampayan, MD

Topic Presenter

University of Michigan

Jordan Alana Ciuro, MD

Topic Presenter

Emory Winship Cancer Institute

Janaki Sharma, MD

Topic Presenter

Sylvester Cancer Center, Univ of Miami

Spencer Henick Bachow, MD

Topic Presenter

Miami Cancer Insititute at Baptist Health South Florida

Vinay Minocha, MD

Panelist

University of Miami

Jan Krzysztof Rudzinski, MD

Panelist

Raju Vaddepally, MD

Panelist

Agenda

Saturday, November 14th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

08:00 AM - 08:05 AMWelcome

08:05 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities *This is a non-CME accredited activity*

08:30 AM - 09:45 AMSession 1: Management of newly diagnosed mAPMN (mCSPC) prostate cancer

Session Chair: Rohan Garje, MD; Michael Carducci, MD

08:30 AM - 08:40 AM

Case Presentation: The case for upfront PSMA radioligand therapy: Should Pluvicto become the first-line standard for all PSMA-positive mAPMN/S prostate cancer?

08:40 AM - 08:50 AM

Case Presentation: The case for chemotherapy intensification: When is ADT + ARPI + docetaxel the preferred first-line triplet in mAPMN/S prostate cancer?

08:50 AM - 09:05 AM

Case-Based Panel Discussion

Moderators:

Rohan Garje, MD; Michael Carducci, MD

Panelists:

Vinay Minocha, MD

09:05 AM - 09:15 AM

Case Presentation: Upfront PARP inhibition in mAPMN/S prostate cancer: Is BRCA2 the defining biomarker, and who benefits beyond it?

09:15 AM - 09:25 AM

Case Presentation: Capivasertib + abiraterone + ADT in PTEN-deficient mAPMN/S prostate cancer: Defining the ideal candidate? – Jingsong Zhang, MD, PhD

09:25 AM - 09:45 AM

Case-Based Panel Discussion

Moderators:

Rohan Garje, MD; Michael Carducci, MD

Panelists:

Vinay Minocha, MD

09:45 AM - 11:00 AMSession 2: Renal cell carcinoma — State of the art

Session Chair: Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

09:45 AM - 09:55 AM

Case Presentation: The localized renal mass: Surgery, ablation, radiation, or surveillance?

09:55 AM - 10:05 AM

Case Presentation: Adjuvant therapy after nephrectomy: Who should we treat and with what?

10:05 AM - 10:20 AM

Case-Based Panel Discussion

Moderators:

Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

Panelists:

Raju Vaddepally, MD

10:20 AM - 10:30 AM

Case Presentation: Metastatic disease: Choosing first-line therapy in clear-cell non–clear-cell

10:30 AM - 10:40 AM

Case Presentation: Non–clear-cell RCC: Histology, molecular drivers, and treatment selection

10:40 AM - 11:00 AM

Case-Based Panel Discussion

Moderators:

Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD

Panelists:

Raju Vaddepally, MD

11:00 AM - 11:15 AMBreak & Exhibits

11:15 AM - 12:30 PMSession 3: Bladder cancer

Session Chair: Arnab Basu, MD; Manuel Ozambela, MD

11:15 AM - 11:25 AM

Case Presentation: Choosing among options in BCG-unresponsive NMIBC

11:25 AM - 11:35 AM

Case Presentation: Perioperative systemic therapy for MIBC — a moving target

11:35 AM - 11:50 AM

Case-Based Panel Discussion

Moderators:

Arnab Basu, MD; Manuel Ozambela, MD

Panelists:

Jan Krzysztof Rudzinski, MD

11:50 AM - 12:00 PM

Case Presentation: Bladder preservation options among patients with MIBC

12:00 PM - 12:10 PM

Case Presentation: Ideal systemic therapy for metastatic urothelial carcinoma

12:10 PM - 12:30 PM

Case-Based Panel Discussion

Moderators:

Arnab Basu, MD; Manuel Ozambela, MD

Panelists:

Jan Krzysztof Rudzinski, MD

12:30 PM - 01:30 PM Lunch & Exhibits

01:30 PM - 02:45 PMSession 4: Symptom management, survivorship & well-being

01:30 PM - 01:40 PM

Case Presentation: Symptom management

01:40 PM - 01:50 PM

Case presentation: Drug interaction

01:50 PM - 02:05 PM

Case-Based Panel Discussion

02:05 PM - 02:15 PM

Case Presentation: Nurse navigator

02:15 PM - 02:25 PM

Case Presentation: Role of research coordinator in clinical trials

02:25 PM - 02:45 PM

Case-Based Panel Discussion

About Miami GU Oncology Summit

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Agenda

Venue and map

Registration and pricing

Exhibitors and sponsorship

Our Speakers

Planning Committee

Faculty

Agenda